> Detailanzeige

Wenzel, Katrin; Rajakumar, Augustine; Haase, Hannelore; Geusens, Nele; Hubner, Norbert; Schulz, Herbert; Brewer, Justin; Roberts, Lyndsay; Hubel, Carl A.; Herse, Florian; Hering, Lydia; Qadri, Fatimunnisa; Lindschau, Carsten; Wallukat, Gerd; Pijnenborg, Robert; Heidecke, Harald; Riemekasten, Gabriela; Luft, Friedrich C.; Muller, Dominik N.; Lamarca, Babette; Dechend, Ralf

Angiotensin II Type 1 Receptor Antibodies and Increased Angiotensin II Sensitivity in Pregnant Rats

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Angiotensin II Type 1 Receptor Antibodies and Increased Angiotensin II Sensitivity in Pregnant Rats
  • Beteiligte: Wenzel, Katrin; Rajakumar, Augustine; Haase, Hannelore; Geusens, Nele; Hubner, Norbert; Schulz, Herbert; Brewer, Justin; Roberts, Lyndsay; Hubel, Carl A.; Herse, Florian; Hering, Lydia; Qadri, Fatimunnisa; Lindschau, Carsten; Wallukat, Gerd; Pijnenborg, Robert; Heidecke, Harald; Riemekasten, Gabriela; Luft, Friedrich C.; Muller, Dominik N.; Lamarca, Babette; Dechend, Ralf
  • Erschienen: Ovid Technologies (Wolters Kluwer Health), 2011
  • Erschienen in: Hypertension, 58 (2011) 1, Seite 77-84
  • Sprache: Englisch
  • DOI: 10.1161/hypertensionaha.111.171348
  • ISSN: 0194-911X; 1524-4563
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Pregnant women who subsequently develop preeclampsia are highly sensitive to infused angiotensin (Ang) II; the sensitivity persists postpartum. Activating autoantibodies against the Ang II type 1 (AT 1 ) receptor are present in preeclampsia. In vitro and in vivo data suggest that they could be involved in the disease process. We generated and purified activating antibodies against the AT 1 receptor (AT 1 -AB) by immunizing rabbits against the AFHYESQ epitope of the second extracellular loop, which is the binding epitope of endogenous activating autoantibodies against AT 1 from patients with preeclampsia. We then purified AT 1 -AB using affinity chromatography with the AFHYESQ peptide. We were able to detect AT 1 -AB both by ELISA and a functional bioassay. We then passively transferred AT 1 -AB into pregnant rats, alone or combined with Ang II. AT 1 -AB activated protein kinase C-α and extracellular-related kinase 1/2. Passive transfer of AT 1 -AB alone or Ang II (435 ng/kg per minute) infused alone did not induce a preeclampsia-like syndrome in pregnant rats. However, the combination (AT 1 -AB plus Ang II) induced hypertension, proteinuria, intrauterine growth retardation, and arteriolosclerosis in the uteroplacental unit. We next performed gene-array profiling of the uteroplacental unit and found that hypoxia-inducible factor 1α was upregulated by Ang II plus AT 1 -AB, which we then confirmed by Western blotting in villous explants. Furthermore, endothelin 1 was upregulated in endothelial cells by Ang II plus AT 1 -AB. We show that AT 1 -AB induces Ang II sensitivity. Our mechanistic study supports the existence of an “autoimmune-activating receptor” that could contribute to Ang II sensitivity and possible to preeclampsia.
  • Zugangsstatus: Freier Zugang